表紙
市場調査レポート

大腸菌感染症:世界の治験動向

Escherichia Coli Infections Global Clinical Trials Review, H1, 2015

発行 GlobalData 商品コード 177211
出版日 ページ情報 英文 74 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
大腸菌感染症:世界の治験動向 Escherichia Coli Infections Global Clinical Trials Review, H1, 2015
出版日: 2015年06月25日 ページ情報: 英文 74 Pages
概要

当レポートでは、大腸菌感染症の治験 (臨床試験) に関する最新動向について分析しており、地域別の治験件数、治験の段階別進行状況、被験者採用の状況、有望なスポンサー、各企業や研究機関における研究の進行状況、有望な薬剤の比較といった情報をまとめています。

イントロダクション

  • 大腸菌感染症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:感染症治療薬の治験における大腸菌感染症の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

大腸菌感染症治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • 帝人
    • NIZO food research BV
    • Bellus Health Inc.
    • Thallion Pharmaceuticals Inc. (Inactive)
    • Pfizer Inc.
    • GlaxoSmithKline Plc
    • Cubist Pharmaceuticals, Inc.
    • Berna Biotech Ltd
    • Arla Foods amba
    • Alexion Pharmaceuticals, Inc.
  • 代表的な研究機関・病院の治験の概要
    • The National Institute of Allergy and Infectious Diseases
    • Assistance Publique - Hopitaux de Paris
    • Medical University of Vienna
    • The Hong Kong Polytechnic University
    • Uppsala University

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2739CTIDB

GlobalData's clinical trial report, "Escherichia Coli Infections Global Clinical Trials Review, H1, 2015" provides an overview of Escherichia Coli Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Escherichia Coli Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Escherichia Coli Infections
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Escherichia Coli Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Escherichia Coli Infections
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Escherichia Coli Infections Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Teijin Limited
      • Clinical Trial Overview of Teijin Limited
      • NIZO food research BV
      • Clinical Trial Overview of NIZO food research BV
      • Bellus Health Inc.
      • Clinical Trial Overview of Bellus Health Inc.
      • Thallion Pharmaceuticals Inc. (Inactive)
      • Clinical Trial Overview of Thallion Pharmaceuticals Inc. (Inactive)
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • GlaxoSmithKline Plc
      • Clinical Trial Overview of GlaxoSmithKline Plc
      • Cubist Pharmaceuticals, Inc.
      • Clinical Trial Overview of Cubist Pharmaceuticals, Inc.
      • Berna Biotech Ltd
      • Clinical Trial Overview of Berna Biotech Ltd
      • Arla Foods amba
      • Clinical Trial Overview of Arla Foods amba
      • Alexion Pharmaceuticals, Inc.
      • Clinical Trial Overview of Alexion Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • The Hong Kong Polytechnic University
      • Clinical Trial Overview of The Hong Kong Polytechnic University
      • Uppsala University
      • Clinical Trial Overview of Uppsala University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Escherichia Coli Infections Therapeutics, Global, Clinical Trials by Region, 2015*
  • Escherichia Coli Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Escherichia Coli Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Escherichia Coli Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015*
  • Escherichia Coli Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Escherichia Coli Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Escherichia Coli Infections Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Escherichia Coli Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Escherichia Coli Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Escherichia Coli Infections Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Escherichia Coli Infections Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Escherichia Coli Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Teijin Limited, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by NIZO food research BV, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Bellus Health Inc., 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Thallion Pharmaceuticals Inc. (Inactive), 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Cubist Pharmaceuticals, Inc., 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Berna Biotech Ltd, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Arla Foods amba, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexion Pharmaceuticals, Inc., 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hong Kong Polytechnic University, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Uppsala University, 2015*

List of Figures

  • Escherichia Coli Infections Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Escherichia Coli Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Escherichia Coli Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Escherichia Coli Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015*
  • Escherichia Coli Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Escherichia Coli Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Escherichia Coli Infections Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Escherichia Coli Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Escherichia Coli Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Escherichia Coli Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Escherichia Coli Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top